Hyundai Steel Co. and Samsung Electronics Co. have developed technology to utilize calcium fluoride (CaF2) from recycled wastewater sludge as supplementary material in steelmaking.
The CaF2 is similar to fluorite, a steelmaking material that lowers melting temperatures and removes impurities in molten iron.
The new technology allows Hyundai Steel, the country’s No. 2 steelmaker, to cut costs while reducing Samsung’s semiconductor waste.
South Korean steelmakers have to entirely import fluorite.
Hyundai Steel imports about 20,000 tons of fluorite annually. With the new recycling technology, Hyundai Steel expects to cut its imports by half as early as the end of October.
Without the technology, Samsung would either throw away wastewater sludge or send it to cement factories for reuse.
The process began last year with a partnership agreement signed by Hyundai Steel and Samsung with local metal recycling firm Pos Ceramics Co. to jointly develop recycling technology for wastewater sludge.
In April of this year, Hyundai Steel was able to produce steel using 30 tons of fluorite alternatives.
The new technology was approved in August by South Korean authorities, including the National Institute of Environmental Research, approved the new technology in August.


Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Blue Origin New Glenn Rocket Explodes During Launch Pad Test, Delaying Space Ambitions
NASA Cuts Boeing Starliner Missions as SpaceX Pulls Ahead
Australia Consumer Sentiment Rises in July as Fuel Price Relief Lifts Confidence
Gold Price Holds Near $4,000 as Middle East Tensions and Fed Rate Hike Bets Grow
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
US Inflation Expected to Ease in June, but Fed Rate Hike Risks Persist Amid Middle East Tensions
China Trade Surplus Hits $125.6 Billion as June Exports, Imports Smash Forecasts
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
South Korea’s KOSPI Triggers Trading Curb as AI Chip Stock Selloff Deepens
Asia Stocks Slip as Iran-Hormuz Tensions Lift Oil Prices, Dollar and Bond Yields
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
Dollar Eases as Middle East Conflict, Fed Outlook and Japan Pension Policy Drive FX Markets
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 



